Posted by Michael Wonder on 19 Oct 2023
Novavax receives full marketing authorisation for prototype COVID-19 vaccine Nuvaxovid in United Kingdom
18 October 2023 - Full authorisation of prototype enables rapid authorisation of updated Novavax COVID-19 vaccines in future.
Novavax today announced that the MHRA in the United Kingdom has granted full marketing authorisation for its prototype COVID-19 vaccine Nuvaxovid (NVX-CoV2373) for individuals aged 12 and older for active immunisation to help prevent COVID-19.
